Ana Pereira
Works at
Icahn School of Medicine at Mount Sinai
Lead investigator
Sources: openalex.org
Grants and prizes
Alzheimer's Drug Discovery Foundation
Clinical, Glutamatergic Dysfunction in Cognitive Aging: Riluzole in Mild Cognitive Impairment - Expansion to an additional clinical site, ADDF-21090077, 2018–2020, 1 Mar 2018
Alzheimer's Disease Research: Standard, GLT-1 Pathophysiological Mechanisms and as a Target to Treat Alzheimer’s Disease, A2016478S, 2016–2019, 1 Jul 2016
Sources: openalex.org